ReviewBiomolecules2025

Comparative Insights on IL-5 Targeting with Mepolizumab and Benralizumab: Enhancing EGPA Treatment Strategies.

Mayu Shiomi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.